drugset
drugset / Trial / NCT07134465

Clinical Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of HSK31858 in Healthy Subjects

NCT07134465 ↗

Phase 1 Enrolling by invitation 24 enrolled Haisco Pharmaceutical Group Co., Ltd.
NaSingle-groupOpen-labelTreatment

Summary

This is a single-center, open-label, two-period, fixed-sequence clinical study to evaluate the effect of Itraconazole on the pharmacokinetics of HSK31858 in healthy subjects

Timeline

Start
2025-08-11
Primary completion
2026-11-30
Completion
2026-11-30

Drugs

EvaluationDrugModalityDoseRoute
Subject HSK31858 Unknown 40 mg —
Subject Itraconazole Small molecule 200 mg —

Indications

No indication recorded.